Efficacy and safety of abrocitinib versus dupilumab in adults with moderate-to-severe atopic dermatitis: a randomised, double-blind, multicentre phase 3 trial von Reich, Kristian, Thyssen, Jacob P, Blauvelt, Andrew, Eyerich, Kilian, Soong, Weily, Rice, Zakiya P, Hong, H Chih-ho, Katoh, Norito, Valenzuela, Fernando, DiBonaventura, Marco, Bratt, Tamara A, Zhang, Fan, Clibborn, Claire, Rojo, Ricardo, Valdez, Hernan, Kerkmann, Urs

Volltext

CLINICAL PRESENTATION AND QUALITY OF LIFE BURDEN ASSOCIATED WITH HYPERHIDROSIS IN CHILDREN AND ADOLESCENTS von Rice, ZP, Pieretti, LJ, Wheeler, A, Payne, J, Gillard, KK, Devlin, T, Sidbury, R, Hebert, AA

Volltext

Comparing how well abrocitinib and dupilumab treat atopic dermatitis signs and symptoms: a plain language summary von Reich, Kristian, Thyssen, Jacob P., Blauvelt, Andrew, Eyerich, Kilian, Soong, Weily, Rice, Zakiya P., Hong, H. Chih-ho, Katoh, Norito, Valenzuela, Fernando, DiBonaventura, Marco, Bratt, Tamara A., Zhang, Fan, Clibborn, Claire, Rojo, Ricardo, Valdez, Hernan, Kerkmann, Urs

Volltext

Quality of Life Impact and Awareness of Primary Focal Hyperhidrosis in Children and Adolescents von Rice, ZP, Pieretti, LJ, Wheeler, A, Payne, J, Gillard, KK, Hebert, AA

Volltext